Skip to main content
HCA logo

HCA Healthcare, Inc. (HCA) Stock: Price, Forecast & Analyst Target

HCA Healthcare, Inc. (HCA) — MoonshotScore 77/100 (Strong band), calculated Nov 18, 2026. Price $476.35 (-4.96%), as of the Nov 18, 2026 trading session; market cap $99.5B. Expected results Jan 26, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$476.35 −$24.84 (-4.96%) Market Cap $99.5B

HCA Healthcare, Inc. · HCA · NYSE · Healthcare · Medical - Care Facilities

Research dated 2026-09-12: HCA Healthcare delivers hospital and outpatient care across a broad clinical network, collecting revenue from commercial insurers and government programs rather than selling insurance itself. Patient activity and outpatient expansion must keep lifting operating profit while a debt-heavy capital structure limits tolerance for execution setbacks.

Price as of Nov 18, 2026

Key Statistics

77 of 100

MoonshotScore v2 · HCA Healthcare (HCA)

Strong
Business Quality Solid (70)
Financial Safety Okay (50)
Valuation Fair (73)
Growth Durability Compounding (85)
Momentum Surging (86)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and durable growth, though the balance sheet is only middling; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Compounding; Momentum: Surging.

  • EPS beat 0 of the last 4 reports
  • expected results Jan 26, 2027
  • Altman Z 2.56 · Piotroski F 6

Helping: business quality, an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for HCA (57 recorded, newest six shown)
RecordedScoreBand
73Strong
80Exceptional
80Exceptional
80Exceptional
77Strong
77Strong

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$476.35
Change on the day-4.96%
52-week range$353.99–$556.52
Market capitalisation$99.5B—
Price / earnings (trailing)16.56
Shares traded on the day1.60M
Beta (volatility vs the S&P 500)1.11

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $371, high $540, latest $476. 4 reported quarters marked, 4 above and 0 below the recorded estimate. $540 $371 high $540 Jan 27, 2026 · Earnings results · reported above the recorded estimate · close $4881Apr 24, 2026 · Earnings results · reported above the recorded estimate · close $4322Jul 24, 2026 · Earnings results · reported above the recorded estimate · close $3823Oct 27, 2026 · Earnings results · reported above the recorded estimate · close $4734 Oct 17, 2025 Nov 18, 2026 · $476 $426Oct 17, 2025$460Oct 31, 2025$473Nov 14, 2025$508Nov 28, 2025$485Dec 12, 2025$477Dec 26, 2025$472Jan 9, 2026$471Jan 23, 2026$502Feb 6, 2026$532Feb 20, 2026$533Mar 6, 2026$494Mar 20, 2026$472Apr 2, 2026$488Apr 17, 2026$433May 1, 2026$423May 15, 2026$379May 29, 2026$387Jun 12, 2026$392Jun 26, 2026$407Jul 10, 2026$382Jul 24, 2026$413Aug 7, 2026$429Aug 21, 2026$405Sep 4, 2026$428Sep 18, 2026$427Oct 2, 2026$459Oct 16, 2026$473Oct 30, 2026$499Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for HCA Healthcare (HCA): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Neutral
Valuation Moderate
Growth Durability Strong
Momentum Strong

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Neutral
Revenue Growth Neutral
Gross Margin Moderate

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is HCA Healthcare (HCA), and what does it report?

Short answer · as of

HCA is a care-delivery network spanning acute hospitals, emergency care, surgery, imaging, rehabilitation, oncology, physician practices and psychiatric treatment.

Its revenue measures care funded through distinct payer channels, with managed care and other insurers forming the largest category and managed Medicare also carrying substantial weight.

Annual revenue advanced throughout the displayed history. Net income recovered from its trough as revenue continued rising, showing that the earnings path depends on how efficiently additional care volume passes through the network.

2 · Latest results

What do the latest results show for HCA Healthcare (HCA)?

The latest period produced the highest quarterly revenue in the displayed series, while operating profit and net income improved from the immediately preceding period. Reported revenue and earnings also exceeded market estimates, continuing a run of earnings outcomes above expectations.

Those are reported outcomes. Management separately attributes prospective operating leverage to volume growth and says its resilience initiatives should improve cost trends, while the cash-flow record shows that operating cash generation remains positive but variable.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$19.85B Oct 27, 2026
Latest report · revenue estimate
$19.33B Oct 27, 2026
Latest report · revenue vs estimate
Above estimate Oct 27, 2026
Latest report · EPS vs estimate
Above estimate Oct 27, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Oct 27, 2026$19.85B$19.33B$7.2200$6.6500
Jul 24, 2026$20.23B$19.76B$7.5900$7.5600
Apr 24, 2026$19.11B$19.09B$7.1500$7.1200
Jan 27, 2026$19.51B$19.68B$8.0100$7.4600
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$19.16B$1.64B$6.96 (diluted)
Q4 FY2025$19.51B$1.88B$8.14 (diluted)
Q1 FY2026$19.11B$1.62B$7.15 (diluted)
Q2 FY2026$20.23B$1.70B$7.62 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for HCA Healthcare (HCA)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Operations consistently generated cash across the displayed periods, and cash remaining after capital expenditure stayed positive despite heavy investment in facilities. That cash engine is the principal financial support for a network requiring persistent capital spending.

Debt towers over cash and investments, while short-term liquidity ratios remain below full coverage. The cash reserve also declined sharply across the reported window, even though recent balances have been comparatively stable; positive operating cash flow therefore has not translated into cash accumulation.

Payer economics and cost control meet directly in HCA’s margins. Weaker reimbursement or renewed cost pressure would become more consequential if operating cash conversion slipped while debt and capital requirements remained elevated.

4 · What to check next?

What should you watch next at HCA Healthcare (HCA)?

Short answer · as of

The next earnings report is expected on Jan 26, 2027.

The scheduled earnings release should be tested against the recent revenue peak, the sequential improvement in operating profit and the durability of cash remaining after capital expenditure. The important observation is not merely whether estimates are cleared, but whether revenue growth continues to produce operating leverage.

Management has linked its growth agenda to a large pipeline of outpatient facilities and its margin outlook to better cost trends. Confirmation would come from sustained volume-led profit growth without renewed cash erosion; deterioration would appear as costs outrunning revenue while capital spending and debt remain heavy.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does HCA Healthcare compare with its peers?

Short answer

HCA Healthcare's score ranks 11th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

HCA should not be read as merely an acute-hospital chain. Its network reaches across hospital care, freestanding emergency and surgery sites, urgent care, diagnostics, rehabilitation, oncology, physician practices and behavioral health, making outpatient expansion a core growth route rather than an incidental service.

The economic reporting lens is payer-based rather than facility-based: managed care and other insurers dominate revenue, alongside managed Medicare, traditional Medicare and Medicaid channels. Comparisons based only on hospital capacity can therefore miss the payer mix that converts clinical activity into revenue.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Tenet Healthcare Corporation (THC) Same industry, near in market value$271.34 Nov 18, 2026$21.6B94 5-pillar Nov 18, 2026
LifeStance Health Group, Inc. (LFST) Same industry, near in market value$13.77 Nov 18, 2026$5.24B92 5-pillar Nov 18, 2026
Universal Health Services, Inc. (UHS) Same industry, near in market value$186.07 Nov 18, 2026$10.7B91 5-pillar Nov 18, 2026
Vertex Pharmaceuticals Incorporated (VRTX) Named competitor$536.45 Nov 18, 2026$136B90 5-pillar Nov 18, 2026
Sanofi (SNY) Named competitor$47.12 Nov 18, 2026$113B87 5-pillar Nov 18, 2026
Bristol-Myers Squibb Company (BMY) Named competitor$59.56 Nov 18, 2026$122B85 5-pillar Nov 18, 2026
Chemed Corporation (CHE) Same industry, near in market value$546.72 Nov 18, 2026$7.09B85 5-pillar Nov 18, 2026
CVS Health Corporation (CVS) Named competitor$81.34 Nov 18, 2026$104B81 5-pillar Nov 18, 2026
Encompass Health Corporation (EHC) Same industry, near in market value$134.94 Nov 18, 2026$13.2B81 5-pillar Nov 18, 2026
Fresenius Medical Care AG & Co. KGaA (FMS) Same industry, near in market value$20.95 Nov 18, 2026$10.9B80 5-pillar Nov 18, 2026
HCA Healthcare (HCA) — this page$476.35$99.5B77
DaVita Inc. (DVA) Same industry, near in market value$161.75 Nov 18, 2026$10.2B76 5-pillar Nov 18, 2026
The Ensign Group, Inc. (ENSG) Same industry, near in market value$182.98 Nov 18, 2026$10.7B74 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$369.00 – $579.00
Consensus target
$466.26
Median target
$485.00

Consensus record · Captured .

Measured against a quoted price of $476.35 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 10, 2026

Transactions
35
Identified insiders
7
Purchases
0
Sales
10
Other transactions
25

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held HCA in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.38%$86.26MTrimmed −0.5% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about HCA Healthcare (HCA)?

Read these with our analysis →

Common Questions About HCA (Healthcare)

The last 2 questions are answered from this page's own dated data, not from the research.

How does HCA earn revenue from managed care patients?

HCA provides clinical services through hospitals and outpatient facilities, while managed-care organizations and other insurers fund the largest reported revenue category. Revenue therefore depends on care activity and the economics attached to the payer channel.

What does HCA’s outpatient expansion change about its hospital-centered model?

The expansion adds more entry points for surgery, emergency care, diagnostics, rehabilitation and physician services beyond the hospital campus. Management’s facility pipeline makes these settings a material route for extending the care network.

Why can HCA generate cash while its cash reserve declines?

Operating cash flow has remained positive and has exceeded capital expenditure throughout the displayed periods, yet the cash balance fell materially across the broader window. Cash generation from operations therefore does not describe every use of capital affecting the reserve.

Did HCA’s latest revenue gain strengthen operating profit?

Quarterly revenue reached the high point of the displayed series, and operating profit improved from the preceding period. Management says volume growth created operating leverage, while continued cost improvement remains an execution test.

What is the HCA stock price today?

The last price recorded for HCA Healthcare, Inc. (HCA), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the HCA price target?

The analyst consensus price target for HCA Healthcare, Inc. (HCA), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 41 figures on this page — 1 from SEC filings and earnings calls, 34 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Quarterly income statement (USD thousands); Cash, investments and debt; Management outlook — dated call excerpts
  • 1. What is HCA Healthcare (HCA), and what does it report?: Business description; Revenue by segment; Annual revenue and net result (USD millions)
  • 2. What do the latest results show for HCA Healthcare (HCA)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts; Operating cash flow by quarter (USD millions)
  • 3. What are the financial strengths and risks for HCA Healthcare (HCA)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Trailing twelve-month ratio set; Revenue by segment; Management outlook — dated call excerpts
  • 4. What should you watch next at HCA Healthcare (HCA)?: Next earnings report; Analyst revenue and earnings estimates (average); Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash, investments and debt; Management outlook — dated call excerpts
  • 5. How does HCA Healthcare compare with its peers?: Business description; Revenue by segment; Management outlook — dated call excerpts
  • FAQ: How does HCA earn revenue from managed care patients?: Business description; Revenue by segment
  • FAQ: What does HCA’s outpatient expansion change about its hospital-centered model?: Business description; Management outlook — dated call excerpts
  • FAQ: Why can HCA generate cash while its cash reserve declines?: Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash and investment components
  • FAQ: Did HCA’s latest revenue gain strengthen operating profit?: Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold HCA

Funds in our ETF coverage that list HCA among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
SMI 3Fourteen Full-Cycle Trend ETF (FCTE)5.39%
IHF ETF5.28%
FLDZ ETF0.51%